cerrar
Tagged with EY

Swiss Biotech’s Funding Quandary
"Access to funding is critical for innovative biotech startups, and the Swiss funding landscape is very fragmented" Martin Rohrbach, KPMG

Interview: Keith Lostaglio – Partner, Head of Health…
According to A.T. Kearney Health Practice Partner Keith Lostaglio, Southeast Asia presents a significant growth opportunity to the pharma industry,…

Interview: Sorcha McKenna – Partner, McKinsey &…
Sorcha McKenna, Partner at McKinsey & Company in Ireland, discusses the current trends in the Irish healthcare and life sciences sector, the…

Interview: Aidan Meagher – Tax Partner & Irish Life…
Aidan Meagher, Tax Partner & Irish Life Sciences Lead for EY Ireland, discusses EY’s extensive consulting work, including their efforts to…

Emerging Asia: Leading the Digital Charge
“Cloud-based technology, mobile enablement and fees for service models will lead to faster deployment and increased benefits for patients. Perhaps…

Asia-Pacific Healthcare: Managing Diversity
The Asia-Pacific region is a vast geographic area, home to almost half of the world’s population and numerous emerging and developed markets with…

Interview: Martin Dewhurst – Senior Partner, Co-convenor of…
Martin Dewhurst of the Global Pharmaceuticals and Medical Products Practice at McKinsey & Company provides his view of the Asia Pacific Medtech…

Interview: Weston Stacey – Executive Director, AmCham Czech…
The executive director of the American Chamber of Commerce in the Czech Republic discusses measuring the impact that healthcare policy changes have on…

Interview: Jean-François Mouney – CEO & Chairman,…
Genfit’s Jean-François Mouney speaks about responding to high unmet medical needs in inflammatory and metabolic related diseases. With the increase…

Interview: Jane Griffiths – Company Group Chairman, Europe,…
In an exclusive interview at the eyeforpharma Barcelona Summit 2016, Janssen EMEA's Jane Griffiths speaks out about patient-centricity,…

Sustainability and Patient-Value Dominate Key Pharma Summit
The pharmaceutical industry needs to work harder to demonstrate the value that it delivers to society and to the greater economy by advancing public…

Interview: Richie Etwaru – Chief Digital Officer (CDO), IMS…
In part II of an exclusive interview at the eyeforpharma Barcelona Summit 2016, IMS Health’s Chief Digital Officer Richie Etwaru lifts the lid on…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here